GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (NAS:COO) » Definitions » Days Sales Outstanding

The Cooper (The Cooper) Days Sales Outstanding : 61.74 (As of Jan. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Days Sales Outstanding?

The Cooper's average Accounts Receivable for the three months ended in Jan. 2024 was $630 Mil. The Cooper's Revenue for the three months ended in Jan. 2024 was $932 Mil. Hence, The Cooper's Days Sales Outstanding for the three months ended in Jan. 2024 was 61.74.

The historical rank and industry rank for The Cooper's Days Sales Outstanding or its related term are showing as below:

COO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.81   Med: 56.25   Max: 65.37
Current: 60.47

During the past 13 years, The Cooper's highest Days Sales Outstanding was 65.37. The lowest was 49.81. And the median was 56.25.

COO's Days Sales Outstanding is ranked better than
54.03% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs COO: 60.47

The Cooper's Days Sales Outstanding increased from Jan. 2023 (60.56) to Jan. 2024 (61.74).


The Cooper Days Sales Outstanding Historical Data

The historical data trend for The Cooper's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Days Sales Outstanding Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.71 65.37 59.37 59.20 59.30

The Cooper Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.56 59.62 58.59 61.00 61.74

Competitive Comparison of The Cooper's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, The Cooper's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where The Cooper's Days Sales Outstanding falls into.



The Cooper Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

The Cooper's Days Sales Outstanding for the fiscal year that ended in Oct. 2023 is calculated as

Days Sales Outstanding (A: Oct. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2022 ) + Accounts Receivable (A: Oct. 2023 )) / count ) / Revenue (A: Oct. 2023 )*Days in Period
=( (557.8 + 609.7) / 2 ) / 3593.2*365
=583.75 / 3593.2*365
=59.30

The Cooper's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

Days Sales Outstanding (Q: Jan. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2023 ) + Accounts Receivable (A: Jan. 2024 )) / count ) / Revenue (A: Jan. 2024 )*Days in Period
=( (609.7 + 651) / 2 ) / 931.6*365 / 4
=630.35 / 931.6*365 / 4
=61.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (NAS:COO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


The Cooper Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of The Cooper's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (The Cooper) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Executives
Gary S Petersmeyer director 3400 CENTRAL AVENUE, SANTA CLARA CA 95051
Robert S Weiss director, officer: EVP and CFO 6140 STANERIDGE MALL RES #590, PLEASSANTON CA 94503
Agostino Ricupati officer: Sr. VP, Finance & Tax C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Warner Gerard H Iii officer: President, CooperVision, Inc. C/O COOPER COMPANIES INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583
Jody S Lindell director 2536 FILLMORE ST., SAN FRANCISCO CA 94115
Cynthia L Lucchese director 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260
Nicholas Khadder officer: VP, General Counsel & Corp Sec 2836 JOHNSON AVENUE, ALAMEDA CA 94501
Daniel G Mcbride officer: VP and Senior Counsel 5 EL CORTE, ORINDA CA 94563
Brian G Andrews officer: Treasurer 4300A 17TH STREET, SAN FRANCISCO CA 94114
Maria Rivas director C/O MEDIDATA SOLUTIONS, INC., 350 HUDSON STREET, 9TH FLOOR, NEW YORK NY 10014
White Albert G Iii officer: VP & Treasurer 6790, SPRINGDALE COURT, VICTOR NY 14564
Teresa S Madden director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Robert D Auerbach officer: President, CSI C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588
Holly R Sheffield officer: EVP, CSO C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Mark J Drury officer: VP, General Counsel & Sec. C/O COOPERCOMPANIES, 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583

The Cooper (The Cooper) Headlines